NCT07476495Recruiting
Insights on Dissemination of Lung Cancer
Source: ClinicalTrials.gov · Last updated 17 Mar 2026
Brief summary (registry, in English)
In patients with resectable NSCLC treated with surgery alone or with surgery as part of a multimodal treatment; CTC, ctDNA, STAS, and lymph node micrometastasis levels will be evaluated to see if they are associated with recurrence patterns and long-term outcomes.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 6 Mar 2026
- Start date
- Feb 2026
- Primary completion date
- Feb 2029
- Lead sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Diseases
- Lung cancer
- NCT number
- NCT07476495
What you commit to
- Study type: Observational
- Planned participants: 100
- From Feb 2026 to the primary completion date, Feb 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Other neoplastic diseases concurrent with or undergoing treatment or treated with systemic therapies in the previous three years;
- No need for surgery.
Age
- Age \<18 years;
Other
- Histology other than adenocarcinoma or squamous cell carcinoma;
Who the study is looking for
- Age ≥ 18 years;
- Preoperative diagnosis of resectable stage cIA-cIIIA NSCLC (adenocarcinoma or squamous cell carcinoma);
- Patients deemed fit for surgical or multimodal treatment;
- Informed consent obtained;
- Treatment, including multimodal treatment, involving surgery.
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS Azienda Ospedaliero-Università di Bologna Coordinator of this site? Confirm its status | Bologna | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.